Watch

BHVNBiohaven Ltd.

Healthcare · Biotechnology · mid-cap ($2.1B)
-27.3%
from rolling 252-day high of $18.57 set 2025-10-30 · 294d ago
Current
$13.50
Decline depth
-27.3%
Decline σ
3.8σ
TFC
3/5 bearish
Rolling 252-day high Up day Down day Last 90 trading days · data from Alpaca

Since tracking began

$BHVN has been tracked since 2026-03-01. It was down 69.1% from its 52-week high then — now down -27.3%.

It has clawed back 5.3 percentage points off that level. It bottomed 78.8% below that high along the way.

Decline from the 52-week high as it stood on 2026-03-02 (fixed anchor) → today. Split-adjusted, Alpaca. Observed history, not a forecast.

Structural break signals

BHVN qualifies for the Watch on decline depth.

Decline depth
-27.3%
From rolling 252-day high of $18.57, 294d ago. Past the 20% Watch threshold.
Time-frame continuity
3/5 bearish
Latest bar across daily/weekly/monthly/quarterly/yearly time frames. A bar counts as bearish when it's a 2-Down or a red 3. Past the 3/5 Watch threshold.
Decline sigma
3.8σ
Drop from local high over the last 10 bars, expressed in units of the stock's typical daily volatility (3.14% per day).

The structural read

What price action says about BHVN.

BHVN qualifies for the Watch on decline depth — down -27.3% from its rolling 252-day high.

Cross-confirmation: also showing 3/5 bearish time frames.

Upstream TFC read: bearish alignment, current phase daily. Last bar types — daily 3 (red), weekly 2D (red), monthly 1 (red).

Earnings on file: 2026-05-04. Tiering is unaffected by earnings dates — listings reflect price structure only.

Questions about BHVN

What people ask.

Why is BHVN on Broken Stocks?

BHVN qualifies for the Watch on decline depth. It is down -27.3% from its rolling 252-day high of $18.57, set on 2025-10-30 — 294d ago.

Is BHVN a falling knife?

No. The falling-knife label usually implies a steep, severe drop — typically 30% or more from a fresh high. BHVN is down -27.3% from its 52-week high, which qualifies for the Watch tier but is shallower than the falling-knife pattern. It's an early-stage decline rather than a sharp breakdown.

Is BHVN a buy?

Broken Stocks does not issue buy or sell recommendations. The list is a rules-based technical warning system. It tracks structural decline depth and recency — not company quality, management, fundamentals, or news. Always do your own research and consult a licensed advisor.

Where is BHVN trading inside its 52-week range?

At $13.50, BHVN sits 54.3% of the way from its 52-week low ($7.48) to its 52-week high ($18.57). A reading below 25% indicates price is hugging the bottom of the range; above 75%, the top.

How fast has BHVN been declining?

The current 27.3% decline accrued over 294d, which annualizes to roughly -33.9% per year. Annualized pace is a sanity check — a 30% decline in three months is a different signal than a 30% decline over two years.

How does BHVN compare to its sector?

There are 143 other Healthcare tickers on Broken Stocks: 70 Red, 35 Amber, 38 Watch, with 50 showing recovering structural signals. Median sector decline is -36.1% — BHVN's decline is shallower than the sector median.

Does BHVN's earnings date affect its tier?

No. Tiering is decided purely by decline depth and recency of the rolling-high date. The earnings date on file (2026-05-04) is shown for reference only — listings can move tier between scans based on closing prices, regardless of fundamentals or news events.